Navigation Links
Amgen Highlights Data to be Presented at ASH
Date:11/30/2009

es that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.

In addition, sales of our products are affected by the reimbursement policies imposed by third-party payors, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments, domestic and international trends toward managed care and health care cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products. In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarant
'/>"/>

SOURCE Amgen Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
10. Call for Applications: The Amgen Award for Science Teaching Excellence
11. Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... -- As part of its ongoing commitment to provide exceptional ... Katz , MD, MPH, cardiac surgeon and chief medical ... implanted the first HeartMate 3 left ventricular assist device ... part of the prestigious MOMENTUM 3™ Clinical Trial. Bon ... United States—and the first in central Virginia—chosen to evaluate ...
(Date:9/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/tzzq39/investigation ) ... on China,s Trastuzumab Market, 2010-2019" report to their ... by FDA to be used in the clinic in ... major product of Roche. In 2013, the sales value ... After entering China in ...
(Date:9/3/2015)... Sept. 3, 2015 Research and Markets ( ... "Radiology Information Systems Market by Type, Deployment Mode, End ... to 2019" report to their offering. ... at $501.1 Million 2014, and is projected to reach ... from 2014 to 2019. The global ...
Breaking Medicine Technology:Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 3Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 4Investigation Report on China's Trastuzumab (Genentech) Market, 2010-2019 2Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 2Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 3
... Mont., May 12, 2011 Bacterin International Holdings, ... a creator and developer of revolutionary bone graft material ... results for its first quarter ended March 31, 2011. ... materially increased the number of medical facilities in ...
... 12, 2011 InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or ... mesh protective stent system, is happy to announce that ... is India,s first mesh-based coronary stent system and received a ... InspireMD will distribute the MGuard stent through KTPL, one ...
Cached Medicine Technology:Bacterin International Holdings, Inc. Reports First Quarter 2011 Financial Results 2Bacterin International Holdings, Inc. Reports First Quarter 2011 Financial Results 3Bacterin International Holdings, Inc. Reports First Quarter 2011 Financial Results 4Bacterin International Holdings, Inc. Reports First Quarter 2011 Financial Results 5Bacterin International Holdings, Inc. Reports First Quarter 2011 Financial Results 6Bacterin International Holdings, Inc. Reports First Quarter 2011 Financial Results 7Bacterin International Holdings, Inc. Reports First Quarter 2011 Financial Results 8Bacterin International Holdings, Inc. Reports First Quarter 2011 Financial Results 9InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India 2InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India 3InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India 4
(Date:9/3/2015)... ... , ... Real Time Pain Relief (RTPR), makers of the popular ... has signed an official endorsement deal with the company. Originally from New South Wales, ... bull at 15. He is an Australian bull riding champion, following in his uncles’ ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... for LANDESK Management Suite customers, as part of the LANDESK One Partner ... IT, by delivering the best mobile user experience in remote access and control:, ...
(Date:9/3/2015)... ... September 03, 2015 , ... The Linda Hall Library 2015 ... a comet, the IceCube observatory at the South Pole, and the interior of life-extending ... Lecture Series for the world's foremost independently funded research library devoted to science, engineering, ...
(Date:9/3/2015)... Ca (PRWEB) , ... September 03, 2015 , ... According ... a promising and convenient test that may help patients with oropharyngeal cancer (oral cancer) ... in the United States are often caused by HPV infections, which have a high ...
(Date:9/3/2015)... ... 2015 , ... Hunters Creek Retrievers is again honored to salute ... Lab Puppy. Celebrate Fall 2015 with unlimited Free Hugs and K9 Kisses from a ... and Christmas with an extra big smile. , This adorable trained Lab Pup ...
Breaking Medicine News(10 mins):Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 4Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 2Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 4Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 5Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 3Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 3
... redefine traditional notions of aging ... through friendship and fun, FULLERTON, Calif., April 25 ... invisibility. Thanks,to the Red Hat Society (RHS), founded 10 years ago today, ... few friends who donned,red hats and purple outfits in the spirit of ...
... April 24 Amneal Pharmaceuticals, LLC is,pleased to ... for,Amneal,s wholly-owned subsidiary, Amneal Pharmaceuticals of New York, ... Interpharm. The,acquisition includes Interpharm,s facilities on Long Island, ... ANDA,s, technology and,processes., Amneal will use its ...
... at best cost, study says , , THURSDAY, April 24 ... patients in the United States are being referred for ... to physicians who refer patients to their own facilities ... For the study, Dr. Jean M. Mitchell, a professor ...
... difference in survival when compared to expensive lab tests ... switching to a second-line series of drugs for HIV/AIDS ... made on the basis of sophisticated and expensive lab ... is only slightly affected if these decisions are based ...
... Coalition for 21st,Century Medicine (http://www.twentyfirstcenturymedicine.org ), ... innovative diagnostic technology,companies, clinical laboratories, venture capitalists, ... on the passage of the Genetic,Information Nondiscrimination ... morning., The House of Representatives passed ...
... $225,000, CHICAGO, April 24 Many people think ... often grossly,underestimate their future health care costs. Many also ... Medicare and their employers during their,golden years. However, this ... offering retiree health benefits is steadily declining and the,financial ...
Cached Medicine News:Health News:Hats Off to the Red Hat Society, Which Turns 10 Today 2Health News:Hats Off to the Red Hat Society, Which Turns 10 Today 3Health News:Agreement Executed for Amneal Pharmaceuticals to Acquire the Assets of Interpharm Holdings 2Health News:Increase in Diagnostic Imaging Fueled by Self-Referring Doctors 2Health News:Clinical Symptoms Enough to Switch Drug Regimens for HIV Patients 2Health News:Clinical Symptoms Enough to Switch Drug Regimens for HIV Patients 3Health News:Coalition for 21st Century Medicine Congratulates U.S. Senate on Passage of Genetic Information Nondiscrimination Act 2Health News:Health Insurance a Key Component in Financial Planning 2
Duet Lumbar Allografts are comprised of a raised cancellous inner core providing biomechanical properties for rapid healing. Specially designed instruments facilitate the insertion of Duet Allografts...
... is machined from cortical bone ... graft is machined with a ... and resistance to graft migration. ... bilaterally as a good alternative ...
... of the Metrx system is the same ... nerve root. This is accomplished by applying ... under microscopic visualization. For the first time, ... retraction and discectomy can be performed through ...
Meyerding Laminectomy Retractors, self-retaining....
Medicine Products: